Global News Digest

Science

The Economist

Is playing music good for the brain?

Evidence shows playing music benefits the brain, even for non-professionals.

Higgs boson breakthrough was UK triumph, but British physics faces 'catastrophic' cuts
BBC News

Higgs boson breakthrough was UK triumph, but British physics faces 'catastrophic' cuts

The UK’s pivotal role in the Higgs boson discovery contrasts sharply with current "catastrophic" funding cuts to particle physics, threatening future international collaborations.

The Economist

The next phase of artificial intelligence may require very different processors

GPUs are struggling with rising AI demands, signaling that the next era of artificial intelligence may require completely new hardware.

The Economist

China is a serious contender in the race for fusion energy

China is a serious contender in the global fusion energy race, potentially building the world’s first commercially viable plant.

The Economist

Top AI models underperform in languages other than English

Leading AI models perform poorly in non-English languages, posing the highest danger to patients seeking medical guidance.

The Economist

Rapid-charging EV batteries are on the way

New EV batteries enable charging speeds comparable to refueling gas tanks, significantly reducing wait times for electric vehicle drivers.

The Economist

Should you take GLP-1 drugs for longevity?

GLP-1 drugs show intriguing longevity data, but compelling interest isn't definitive proof. Current evidence remains insufficient to confirm they extend human lifespan.

Artemis II: Nasa targets early April for Moon mission
BBC News

Artemis II: Nasa targets early April for Moon mission

NASA targets early April for the Artemis II launch after resolving a helium leak. The mission will carry four astronauts on a historic ten-day lunar flyby.

The Economist

Want to hack your body with peptides? If only the science agreed

Peptide advocates promise enhanced performance and longevity, yet scientific consensus remains divided on their efficacy and safety.

The Economist

AI is helping expand the frontier of theoretical physics

AI is expanding theoretical physics by blurring the line between instrument and partner, pushing the boundaries of scientific discovery.

The Economist

What is your maximum heart rate?

Learn how to calculate your maximum heart rate. This guide explains the method for determining your peak heart rate.

The Economist

Faecal transplants—a treatment for bipolar disorder?

Early fecal transplant study results for bipolar disorder are intriguing, sparking considerable interest in this potential therapy.

The Economist

A basket of new fruit varieties is coming your way

Gene editing is driving the development of novel fruit varieties, promising a diverse array of new options for consumers soon.

The Economist

Data centres in space: less crazy than you think

Space-based data centers could be cheaper than Earth facilities with the right technology. Equipped with appropriate advancements, they may prove more cost-effective than terrestrial counterparts.

The Economist

Will magnesium supplements help you relax?

Magnesium supplements don't guarantee relaxation for everyone. Individual responses vary, meaning benefits are not universal for all users.

The Economist

Marks left by Stone Age humans were surprisingly complex

Stone Age markings are surprisingly intricate, with information density rivaling early writing.

The Economist

Will one-stop blood tests for cancer save lives?

One-stop blood tests for cancer are gaining widespread popularity, raising hopes that they could significantly save lives through earlier detection.

The Economist

AI tools are being prepared for the physical world

Companies are racing to build AI world models, preparing artificial intelligence systems for practical application in the physical world.

The Economist

Should you be fibremaxxing?

Fibremaxxing is a high-fiber diet trend. Assess if this intense fiber intake aligns with your health goals and tolerance.

The Economist

A psychedelic medicine performs well against depression

A psychedelic medicine showed strong results against depression in a phase III trial, with authorities currently reviewing the findings.